CLCA4 | 23593331 | Diagnostic | Unknown | Tissue | Colon Cancer | The transition from proliferation to differentiation in colorectal cancer is |
GUCA2B | 35151227 | Diagnostic | Unknown | Tissue | Colorectal cancer | Prediction and validation of GUCA2B as the hub-gene in colorectal cancer based on |
GUCA2B | 27688649 | Diagnostic | Unknown | Other | Colon Cancer | Guanylyl cyclase C signaling axis and colon cancer prevention. |
CDH3 | 33639954 | Diagnostic | Unknown | Other | Colorectal cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
CDH3 | 33639954 | Diagnostic | Unknown | Other | Colon Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
TRIP13 | 37750623 | Diagnostic | Unknown | Blood | Colorectal cancer | CYP24A1, AHR, CPEB4, TRIP13, and PIK3CA genes expression in colorectal cancer |
TRIP13 | 34042518 | Diagnostic | Upregulated | Tissue | Colorectal cancer | ASPM is a Novel Candidate Gene Associated with Colorectal Cancer Cell Growth. |
TRIP13 | 34042518 | Diagnostic | Upregulated | Tissue | Colon Cancer | ASPM is a Novel Candidate Gene Associated with Colorectal Cancer Cell Growth. |
MMP11 | 37543577 | Diagnostic | Upregulated | Tissue | Colorectal cancer | Spatial tumour gene signature discriminates neoplastic from non-neoplastic |
MMP11 | 36093604 | Diagnostic | Unknown | Tissue | Colorectal cancer | Germline gain-of-function MMP11 variant results in an aggressive form of |
MMP11 | 35885589 | Diagnostic | Upregulated | Tissue | Colorectal cancer | The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer |
MMP11 | 35837194 | Diagnostic | Unknown | Tissue | Colorectal cancer | Diagnostic genes and immune infiltration analysis of colorectal cancer determined |
MMP11 | 33942633 | Diagnostic | Unknown | Tissue | Colorectal cancer | Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in |
MMP11 | 37543577 | Diagnostic | Upregulated | Tissue | Colon Cancer | Spatial tumour gene signature discriminates neoplastic from non-neoplastic |
MMP11 | 36093604 | Diagnostic | Unknown | Tissue | Colon Cancer | Germline gain-of-function MMP11 variant results in an aggressive form of |
MMP11 | 35885589 | Diagnostic | Upregulated | Tissue | Colon Cancer | The Impact of Matrix Metalloproteinase-11 Polymorphisms on Colorectal Cancer |
MMP11 | 35837194 | Diagnostic | Unknown | Tissue | Colon Cancer | Diagnostic genes and immune infiltration analysis of colorectal cancer determined |
SLCO4A1 | 16895978 | Diagnostic | Unknown | Cell lines | Cancer Related Liver | Molecular determinants in the transport of a bile acid-derived diagnostic agent |
TRIB3 | 35837194 | Diagnostic | Unknown | Tissue | Colorectal cancer | Diagnostic genes and immune infiltration analysis of colorectal cancer determined |
TRIB3 | 34249670 | Diagnostic | Upregulated | Tissue | Colorectal cancer | Systems Biomedicine of Primary and Metastatic Colorectal Cancer Reveals Potential |
TRIB3 | 35837194 | Diagnostic | Unknown | Tissue | Colon Cancer | Diagnostic genes and immune infiltration analysis of colorectal cancer determined |
CEMIP | 28255344 | Diagnostic | Unknown | Tissue | Colon Cancer | Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and in |
GRIN2D | 33639954 | Diagnostic | Unknown | Other | Colorectal cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
GRIN2D | 33639954 | Diagnostic | Unknown | Other | Colon Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
INHBA | 36348017 | Diagnostic | Unknown | Tissue | Cancer Related Liver | DNA methylation status of the SPHK1 and LTB genes underlies the |
PYY | 37373115 | Diagnostic | Unknown | Other | Colorectal cancer | Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. |
PYY | 35837194 | Diagnostic | Unknown | Tissue | Colorectal cancer | Diagnostic genes and immune infiltration analysis of colorectal cancer determined |
PYY | 35837194 | Diagnostic | Unknown | Tissue | Colon Cancer | Diagnostic genes and immune infiltration analysis of colorectal cancer determined |
PYY | 37373115 | Diagnostic | Unknown | Other | Cancer Related Liver | Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. |
PDX1 | 31626200 | Diagnostic | Unknown | Tissue | Colon Cancer | [Differential diagnostic value of the expression of the transcription factor |
PDX1 | 15706433 | Diagnostic | Unknown | Tissue | Colon Cancer | Tissue MicroArray analyses of pancreatic duodenal homeobox-1 in human cancers. |
PDX1 | 33110235 | Diagnostic | Unknown | Tissue | Cancer Related Liver | Metabolic programming of distinct cancer stem cells promotes metastasis of |
BEST4 | 35837194 | Diagnostic | Unknown | Tissue | Colorectal cancer | Diagnostic genes and immune infiltration analysis of colorectal cancer determined |
BEST4 | 35837194 | Diagnostic | Unknown | Tissue | Colon Cancer | Diagnostic genes and immune infiltration analysis of colorectal cancer determined |
RSPO2 | 37022622 | Diagnostic | Unknown | Other | Colorectal cancer | Incidence and clinical significance of 491 known fusion genes in a large cohort |
RSPO2 | 35715628 | Diagnostic | Unknown | Other | Colorectal cancer | Clinicopathological and molecular characteristics of RSPO fusion-positive |
RSPO2 | 35449312 | Diagnostic | Unknown | Other | Colorectal cancer | Comprehensive genetic characterization of rectal cancer in a large cohort of |
RSPO2 | 37022622 | Diagnostic | Unknown | Other | Colon Cancer | Incidence and clinical significance of 491 known fusion genes in a large cohort |
RSPO2 | 35449312 | Diagnostic | Unknown | Other | Colon Cancer | Comprehensive genetic characterization of rectal cancer in a large cohort of |
RSPO2 | 31622618 | Diagnostic | Unknown | Tissue | Colon Cancer | Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of |
RSPO2 | 30901310 | Diagnostic | Unknown | Other | Cancer Related Liver | RSPO2 gene rearrangement: a powerful driver of beta-catenin activation in liver |
BMP3 | 37438612 | Diagnostic | Unknown | Plasma | Colorectal cancer | Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis |
BMP3 | 36058686 | Diagnostic | Unknown | Blood | Colorectal cancer | [The clinical value of multi-target stool fecal immunochemical test-DNA in early |
BMP3 | 34933958 | Diagnostic | Unknown | Blood | Colorectal cancer | Comparison of Performance of Two Stool DNA Tests and a Fecal Immunochemical Test |
BMP3 | 34638449 | Diagnostic | Unknown | Tissue | Colorectal cancer | Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A |
BMP3 | 26401070 | Diagnostic | Unknown | Tissue | Colon Cancer | Stool DNA methylation assays in colorectal cancer screening. |
BMP3 | 24441198 | Diagnostic | Unknown | Tissue | Colon Cancer | DNA methylome profiling identifies novel methylated genes in African American |
SIM2 | 17172723 | Diagnostic | Unknown | Other | Colorectal cancer | Bioinformatics approaches to cancer gene discovery. |
SIM2 | 12530058 | Diagnostic | Unknown | Tissue | Colorectal cancer | Down's syndrome-associated single minded gene as a novel tumor marker. |
SIM2 | 17172723 | Diagnostic | Unknown | Other | Colon Cancer | Bioinformatics approaches to cancer gene discovery. |
SIM2 | 12530058 | Diagnostic | Unknown | Tissue | Colon Cancer | Down's syndrome-associated single minded gene as a novel tumor marker. |
IL6R | 37869102 | Diagnostic | Unknown | Other | Colorectal cancer | Differential gene expression of immunity and inflammation genes in colorectal |
IL6R | 37798688 | Diagnostic | Unknown | Blood | Cancer Related Liver | Study of some potential biomarkers in Egyptian hepatitis C virus patients in |
IL6R | 28270081 | Diagnostic | Unknown | Cell lines | Cancer Related Liver | Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent |
CLDN1 | 38201579 | Diagnostic | Unknown | Other | Colorectal cancer | Claudins-Promising Biomarkers for Selected Gastrointestinal (GI) Malignancies? |
CLDN1 | 37799140 | Diagnostic | Upregulated | Tissue | Colon Cancer | Identification of key claudin genes associated with survival prognosis and |
CLDN1 | 32071364 | Diagnostic | Unknown | Tissue | Colon Cancer | Crosstalk between DNA methylation and gene expression in colorectal cancer, a |
CLDN1 | 37799140 | Diagnostic | Upregulated | Tissue | Cancer Related Liver | Identification of key claudin genes associated with survival prognosis and |
FOXQ1 | 35837194 | Diagnostic | Unknown | Tissue | Colorectal cancer | Diagnostic genes and immune infiltration analysis of colorectal cancer determined |
FOXQ1 | 35837194 | Diagnostic | Unknown | Tissue | Colon Cancer | Diagnostic genes and immune infiltration analysis of colorectal cancer determined |
FOXQ1 | 33639954 | Diagnostic | Unknown | Other | Colon Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
FOXQ1 | 15467436 | Diagnostic | Unknown | Tissue | Colon Cancer | Identification of novel highly expressed genes in pancreatic ductal |
VWA2 | 34433835 | Diagnostic | Unknown | Tissue | Colorectal cancer | Biomolecular imaging of colorectal tumor lesions using a FITC-labeled scFv-Ckappa |
VWA2 | 28886423 | Diagnostic | Unknown | Tissue | Colorectal cancer | Molecular Imaging of Colorectal Tumors by Targeting Colon Cancer Secreted |
VWA2 | 15580307 | Diagnostic | Unknown | Tissue | Colorectal cancer | Colon cancer secreted protein-2 (CCSP-2), a novel candidate serological marker of |
VWA2 | 34433835 | Diagnostic | Unknown | Tissue | Colon Cancer | Biomolecular imaging of colorectal tumor lesions using a FITC-labeled scFv-Ckappa |
VWA2 | 28886423 | Diagnostic | Unknown | Tissue | Colon Cancer | Molecular Imaging of Colorectal Tumors by Targeting Colon Cancer Secreted |
VWA2 | 15580307 | Diagnostic | Unknown | Tissue | Colon Cancer | Colon cancer secreted protein-2 (CCSP-2), a novel candidate serological marker of |
KRT80 | 37782686 | Diagnostic | Upregulated | Tissue | Colorectal cancer | LINC01485 contributes to colorectal cancer progression by targeting |
KRT80 | 33639954 | Diagnostic | Unknown | Other | Colorectal cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
KRT80 | 33639954 | Diagnostic | Unknown | Other | Colon Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
SCARA5 | 32658413 | Diagnostic | Downregulated | Tissue | Colorectal cancer | SCARA5 is a Novel Biomarker in Colorectal Cancer by Comprehensive Analysis. |
CA7 | 26208990 | Diagnostic | Unknown | Tissue | Colorectal cancer | Gene-expression analysis of a colorectal cancer-specific discriminatory |
CA7 | 26208990 | Diagnostic | Unknown | Tissue | Colon Cancer | Gene-expression analysis of a colorectal cancer-specific discriminatory |
VSTM2A | 34253750 | Diagnostic | Upregulated | Other | Colorectal cancer | Transcriptome profiling by combined machine learning and statistical R analysis |
ETV4 | 33639954 | Diagnostic | Unknown | Other | Colon Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
ETV4 | 26015570 | Diagnostic | Unknown | Tissue | Colon Cancer | Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian |
CPNE7 | 38069026 | Diagnostic | Upregulated | Tissue | Colorectal cancer | The Role of CPNE7 (Copine-7) in Colorectal Cancer Prognosis and Metastasis. |
TMIGD1 | 35093172 | Diagnostic | Unknown | Other | Colorectal cancer | Identification of four novel hub genes as monitoring biomarkers for colorectal |
OTOP2 | 37543577 | Diagnostic | Upregulated | Tissue | Colorectal cancer | Spatial tumour gene signature discriminates neoplastic from non-neoplastic |
OTOP2 | 37543577 | Diagnostic | Upregulated | Tissue | Colon Cancer | Spatial tumour gene signature discriminates neoplastic from non-neoplastic |
S100A2 | 34233735 | Diagnostic | Unknown | Urine | Colorectal cancer | Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal |
S100A2 | 30642095 | Diagnostic | Unknown | Other | Colorectal cancer | High-Throughput Omics and Statistical Learning Integration for the Discovery and |
S100A2 | 35107180 | Diagnostic | Upregulated | Other | Cancer Related Liver | Transcriptional activation of S100A2 expression by HIF-1alpha via binding to the |
BLACAT1 | 28406230 | Diagnostic | Unknown | Tissue | Colorectal cancer | Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: |
BIRC5 | 38832035 | Diagnostic | Unknown | Blood | Esophageal cancer | Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing |
BIRC5 | 38832035 | Diagnostic | Unknown | Blood | Esophageal Adenocarcinoma | Anti-BIRC5 autoantibody serves as a valuable biomarker for diagnosing |
BIRC5 | 32210001 | Diagnostic | Upregulated | Tissue | Esophageal Adenocarcinoma | Transcriptomic and Genomic Testing to Guide Individualized Treatment in |
PSMA7 | 38575990 | Diagnostic | Unknown | Tissue | Esophageal cancer | Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in |
CDC25B | 37075603 | Diagnostic | Unknown | Other | Esophageal cancer | Transcriptomic analysis of esophageal cancer reveals hub genes and networks |
CDC25B | 25775393 | Diagnostic | Unknown | Tissue | Esophageal cancer | Expression and significance of CDC25B, PED/PEA-15 in esophageal carcinoma. |
CDC25B | 25775393 | Diagnostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Expression and significance of CDC25B, PED/PEA-15 in esophageal carcinoma. |
CDC25B | 37075603 | Diagnostic | Unknown | Other | Cancer Related Esophageal | Transcriptomic analysis of esophageal cancer reveals hub genes and networks |
CDC25B | 25775393 | Diagnostic | Unknown | Tissue | Cancer Related Esophageal | Expression and significance of CDC25B, PED/PEA-15 in esophageal carcinoma. |
MMP3 | 26631031 | Diagnostic | Upregulated | Other | Esophageal Adenocarcinoma | Diagnostic marker signature for esophageal cancer from transcriptome analysis. |
MCM7 | 35871890 | Diagnostic | Unknown | Tissue | Esophageal cancer | Integrative ontology and pathway-based approach identifies distinct molecular |
MCM7 | 35871890 | Diagnostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Integrative ontology and pathway-based approach identifies distinct molecular |
CXCL8 | 37686093 | Diagnostic | Unknown | Other | Esophageal cancer | Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes. |
CXCL8 | 37433700 | Diagnostic | Unknown | Other | Esophageal cancer | Using Proteome Microarray and Gene Expression Omnibus Database to Screen |
CXCL8 | 36295640 | Diagnostic | Unknown | Tissue | Esophageal cancer | Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous |
CXCL8 | 33926265 | Diagnostic | Unknown | Blood | Esophageal Adenocarcinoma | The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction |
CXCL8 | 30820705 | Diagnostic | Unknown | Blood | Esophageal Adenocarcinoma | Comparison between clinical significance of serum CXCL-8 and classical tumor |
CXCL8 | 37433700 | Diagnostic | Unknown | Other | Esophageal Squamous Cell Carcinoma | Using Proteome Microarray and Gene Expression Omnibus Database to Screen |
CXCL8 | 36295640 | Diagnostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous |
ISG15 | 29555370 | Diagnostic | Unknown | Tissue | Esophageal cancer | ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via |
ISG15 | 29555370 | Diagnostic | Unknown | Tissue | Esophageal Squamous Cell Carcinoma | ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via |
MARCO | 38313230 | Diagnostic | Unknown | Other | Hepatocellular Carcinoma | Current status of magnetic resonance imaging radiomics in hepatocellular |
MARCO | 38326240 | Diagnostic | Unknown | Other | Bile duct cancer | The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric |
MARCO | 33093002 | Diagnostic | Unknown | Tissue | Bile duct cancer | Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 |
MARCO | 32606139 | Diagnostic | Unknown | Other | Bile duct cancer | How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage |
MARCO | 31122681 | Diagnostic | Unknown | Blood | Bile duct cancer | Hypercalcemia of Malignancy in a Dog Diagnosed With Cholangiocellular Carcinoma. |
MARCO | 38326240 | Diagnostic | Unknown | Other | Cholangiocarcinoma | The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric |
MARCO | 34014539 | Diagnostic | Unknown | Tissue | Cholangiocarcinoma | The Heterogeneity of Liver Cancer Metabolism. |
MARCO | 33356500 | Diagnostic | Unknown | Other | Cholangiocarcinoma | Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future |
MARCO | 33093002 | Diagnostic | Unknown | Tissue | Cholangiocarcinoma | Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 |
MARCO | 32668179 | Diagnostic | Unknown | Other | Cholangiocarcinoma | Sicily Network for Liver Cancer: A Multidisciplinary Network Model for the |
MARCO | 32606139 | Diagnostic | Unknown | Other | Cholangiocarcinoma | How to Choose Between Percutaneous Transhepatic and Endoscopic Biliary Drainage |
MARCO | 38313230 | Diagnostic | Unknown | Other | Cancer Related Liver | Current status of magnetic resonance imaging radiomics in hepatocellular |
MARCO | 38092509 | Diagnostic | Unknown | Blood | Cancer Related Liver | Global Burden of Cardiovascular Diseases and Risks, 1990-2022. |
MARCO | 37987917 | Diagnostic | Unknown | Other | Cancer Related Liver | Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic |
NOX4 | 35920301 | Diagnostic | Unknown | Tissue | Hepatocellular Carcinoma | The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC |
NOX4 | 38696908 | Diagnostic | Downregulated | Other | Liver Cancer | Exploration and Validation of Ferroptosis-Associated Genes in ADAR1 |
NOX4 | 38696908 | Diagnostic | Downregulated | Other | Cancer Related Liver | Exploration and Validation of Ferroptosis-Associated Genes in ADAR1 |
NOX4 | 35920301 | Diagnostic | Unknown | Tissue | Cancer Related Liver | The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC |
CDKN3 | 34907098 | Diagnostic | Unknown | Tissue | Hepatocellular Carcinoma | Identification of key genes and carcinogenic pathways in hepatitis B |
CLEC4M | 28403883 | Diagnostic | Upregulated | Blood | Liver Cancer | DC - SIGNR by influencing the lncRNA HNRNPKP2 upregulates the expression of CXCR4 |
CLEC4M | 28109307 | Diagnostic | Unknown | Other | Liver Cancer | Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and |
CLEC4M | 28403883 | Diagnostic | Upregulated | Blood | Cancer Related Liver | DC - SIGNR by influencing the lncRNA HNRNPKP2 upregulates the expression of CXCR4 |
THBS4 | 35456219 | Diagnostic | Unknown | Other | Hepatocellular Carcinoma | Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early |
THBS4 | 33163263 | Diagnostic | Downregulated | Other | Hepatocellular Carcinoma | Landscape of active enhancers developed de novo in cirrhosis and conserved in |
THBS4 | 35456219 | Diagnostic | Unknown | Other | Liver Cancer | Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early |
SCAMP3 | 35816347 | Diagnostic | Unknown | Other | Hepatocellular Carcinoma | Machine learning algorithms based on proteomic data mining accurately predicting |
SCAMP3 | 35816347 | Diagnostic | Unknown | Other | Liver Cancer | Machine learning algorithms based on proteomic data mining accurately predicting |
SCAMP3 | 35816347 | Diagnostic | Unknown | Other | Cancer Related Liver | Machine learning algorithms based on proteomic data mining accurately predicting |
PLVAP | 38318171 | Diagnostic | Unknown | Blood | Hepatocellular Carcinoma | Screening immune-related blood biomarkers for DKD-related HCC using machine |
PLVAP | 38318171 | Diagnostic | Unknown | Blood | Liver Cancer | Screening immune-related blood biomarkers for DKD-related HCC using machine |
PLVAP | 38318171 | Diagnostic | Unknown | Blood | Cancer Related Liver | Screening immune-related blood biomarkers for DKD-related HCC using machine |
ANGPTL6 | 36421714 | Diagnostic | Unknown | Tissue | Hepatocellular Carcinoma | Screening for Lipid-Metabolism-Related Genes and Identifying the Diagnostic |
ANGPTL6 | 36421714 | Diagnostic | Unknown | Tissue | Liver Cancer | Screening for Lipid-Metabolism-Related Genes and Identifying the Diagnostic |
ANGPTL6 | 36421714 | Diagnostic | Unknown | Tissue | Cancer Related Liver | Screening for Lipid-Metabolism-Related Genes and Identifying the Diagnostic |
B4GALNT1 | 29988590 | Diagnostic | Unknown | Other | Hepatocellular Carcinoma | An integrated analysis of genome-wide DNA methylation and gene expression data in |
PRCC | 34715922 | Diagnostic | Unknown | Tissue | Hepatocellular Carcinoma | PRCC reduces the sensitivity of cancer cells to DNA damage by inhibiting JNK and |
PRCC | 33608720 | Diagnostic | Unknown | Tissue | Hepatocellular Carcinoma | Evaluation of Human Kidney Injury Molecule 1 (hKIM-1) Expression in Tumors From |
PRCC | 34715922 | Diagnostic | Unknown | Tissue | Liver Cancer | PRCC reduces the sensitivity of cancer cells to DNA damage by inhibiting JNK and |
PRCC | 33688985 | Diagnostic | Unknown | Blood | Liver Cancer | (18)Fluorodeoxyglucose-positron emission tomography/computed tomography for |
PRCC | 31143076 | Diagnostic | Unknown | Other | Liver Cancer | Recurrent renal cell carcinoma leading to a misdiagnosis of polycystic liver |
PRCC | 34715922 | Diagnostic | Unknown | Tissue | Cancer Related Liver | PRCC reduces the sensitivity of cancer cells to DNA damage by inhibiting JNK and |
CXCL14 | 38482416 | Diagnostic | Unknown | Tissue | Hepatocellular Carcinoma | Construction and validation of a joint diagnosis model based on random forest and |
CXCL14 | 38482416 | Diagnostic | Unknown | Tissue | Liver Cancer | Construction and validation of a joint diagnosis model based on random forest and |
CXCL14 | 38482416 | Diagnostic | Unknown | Tissue | Cancer Related Liver | Construction and validation of a joint diagnosis model based on random forest and |
FBXO43 | 38029156 | Diagnostic | Unknown | Blood | Hepatocellular Carcinoma | F-box protein 43 promoter methylation as a novel biomarker for hepatitis B |
FCN2 | 38482416 | Diagnostic | Unknown | Tissue | Hepatocellular Carcinoma | Construction and validation of a joint diagnosis model based on random forest and |
FCN2 | 38482416 | Diagnostic | Unknown | Tissue | Liver Cancer | Construction and validation of a joint diagnosis model based on random forest and |
FCN2 | 38482416 | Diagnostic | Unknown | Tissue | Cancer Related Liver | Construction and validation of a joint diagnosis model based on random forest and |
PYGO2 | 25797263 | Diagnostic | Downregulated | Tissue | Hepatocellular Carcinoma | Downregulation of miR-432 activates Wnt/beta-catenin signaling and promotes human |
PYGO2 | 25797263 | Diagnostic | Downregulated | Tissue | Liver Cancer | Downregulation of miR-432 activates Wnt/beta-catenin signaling and promotes human |
PYGO2 | 25797263 | Diagnostic | Downregulated | Tissue | Cancer Related Liver | Downregulation of miR-432 activates Wnt/beta-catenin signaling and promotes human |
APLN | 34163524 | Diagnostic | Unknown | Other | Hepatocellular Carcinoma | Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular |
CD34 | 38552058 | Diagnostic | Unknown | Other | Hepatocellular Carcinoma | Sarcomatoid hepatocellular carcinoma: A case report and review of the literature. |
CD34 | 38779190 | Diagnostic | Unknown | Other | Liver Cancer | Benign hepatic schwannoma in a patient with chronic hepatitis B infection: A case |
CD34 | 38552058 | Diagnostic | Unknown | Other | Liver Cancer | Sarcomatoid hepatocellular carcinoma: A case report and review of the literature. |
CD34 | 36366425 | Diagnostic | Unknown | Other | Cholangiocarcinoma | Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel |
CD34 | 34514559 | Diagnostic | Unknown | Other | Cholangiocarcinoma | The Role of Immunocytochemical Markers to Differentiate Primary from Secondary |
CD34 | 38281781 | Diagnostic | Unknown | Tissue | Cancer Related Liver | [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated |
CD34 | 37625828 | Diagnostic | Unknown | Tissue | Cancer Related Liver | C-type Lectin Domain Family 4 Member G (CLEC4G) Is a Negative Marker for CD34 in |
GBA | 36123535 | Diagnostic | Unknown | Tissue | Hepatocellular Carcinoma | Preclinical investigation of artesunate as a therapeutic agent for hepatocellular |
GBA | 37552070 | Diagnostic | Unknown | Other | Liver Cancer | Predicting Infectious Complications after US-guided Ablation of Liver |
COLEC10 | 26154564 | Diagnostic | Unknown | Blood | Liver Cancer | Collectin liver 1 and collectin kidney 1 and other complement-associated pattern |
COL15A1 | 38318171 | Diagnostic | Unknown | Blood | Hepatocellular Carcinoma | Screening immune-related blood biomarkers for DKD-related HCC using machine |
COL15A1 | 35747248 | Diagnostic | Unknown | Tissue | Hepatocellular Carcinoma | Identification and Validation of a Novel Immune Infiltration-Based Diagnostic |
COL15A1 | 38318171 | Diagnostic | Unknown | Blood | Liver Cancer | Screening immune-related blood biomarkers for DKD-related HCC using machine |
COL15A1 | 38318171 | Diagnostic | Unknown | Blood | Cancer Related Liver | Screening immune-related blood biomarkers for DKD-related HCC using machine |
TERT | 37661782 | Diagnostic | Unknown | Other | Bile duct cancer | Genomic Analysis in the Categorization of Poorly Differentiated Primary Liver |
TERT | 37661782 | Diagnostic | Unknown | Other | Cholangiocarcinoma | Genomic Analysis in the Categorization of Poorly Differentiated Primary Liver |
TDRD1 | 31588660 | Diagnostic | Unknown | Tissue | Pancreatic Cancer | Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate |
CD33 | 38799652 | Diagnostic | Downregulated | Blood | Pancreatic Cancer | Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and |
CD33 | 38799652 | Diagnostic | Downregulated | Blood | Pancreatic Ductal Adenocarcinoma | Intra-tumoral administration of CHST15 siRNA remodels tumor microenvironment and |
SPDEF | 38553466 | Diagnostic | Unknown | Other | Pancreatic Cancer | Identification of spatially-resolved markers of malignant transformation in |
SPDEF | 38553466 | Diagnostic | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Identification of spatially-resolved markers of malignant transformation in |
PYY | 38142627 | Diagnostic | Unknown | Other | Pancreatic Cancer | Clinicopathologic features and diagnostic challenges of small cluster pattern |
PYY | 37373115 | Diagnostic | Unknown | Other | Pancreatic Cancer | Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. |
PYY | 28027898 | Diagnostic | Unknown | Blood | Pancreatic Cancer | Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and |
PYY | 28027898 | Diagnostic | Unknown | Blood | Pancreatic Ductal Adenocarcinoma | Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and |
PYY | 28027898 | Diagnostic | Unknown | Blood | Cancer Related Pancreas | Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and |
DDC | 34314825 | Diagnostic | Unknown | Other | Pancreatic Cancer | Non-gaussian models of 3-Tesla diffusion-weighted MRI for the differentiation of |
DDC | 30240758 | Diagnostic | Unknown | Other | Pancreatic Cancer | Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to |
DDC | 29891208 | Diagnostic | Unknown | Tissue | Pancreatic Cancer | Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of |
DDC | 34314825 | Diagnostic | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Non-gaussian models of 3-Tesla diffusion-weighted MRI for the differentiation of |
DDC | 30240758 | Diagnostic | Unknown | Other | Pancreatic Ductal Adenocarcinoma | Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to |
DDC | 29891208 | Diagnostic | Unknown | Tissue | Pancreatic Ductal Adenocarcinoma | Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of |
DDC | 29891208 | Diagnostic | Unknown | Tissue | Cancer Related Pancreas | Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of |
NPL | 36320996 | Diagnostic | Unknown | Other | Pancreatic Cancer | Pancreatic Neuroendocrine Tumor (PNET) Presenting as a Pseudocyst: A Case Report. |
NPL | 36320996 | Diagnostic | Unknown | Other | Pancreatic Exocrine Cancer | Pancreatic Neuroendocrine Tumor (PNET) Presenting as a Pseudocyst: A Case Report. |
SIGLEC7 | 31808236 | Diagnostic | Unknown | Tissue | Pancreatic Cancer | Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as |
CDH3 | 33639954 | Diagnostic | Unknown | Other | Rectal Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
SALL4 | 38131501 | Diagnostic | Unknown | Other | Rectal Cancer | Colostomy-site carcinoma with primitive phenotype in a rectal cancer patient |
SALL4 | 38131501 | Diagnostic | Unknown | Other | Rectum Cancer | Colostomy-site carcinoma with primitive phenotype in a rectal cancer patient |
GRIN2D | 33639954 | Diagnostic | Unknown | Other | Rectal Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
SST | 34388140 | Diagnostic | Unknown | Other | Rectal Cancer | Identifying Bleeding Etiologies by Endoscopy Affected Outcomes in 10,342 Cases |
FOXQ1 | 33639954 | Diagnostic | Unknown | Other | Rectal Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
KRT80 | 33639954 | Diagnostic | Unknown | Other | Rectal Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
FUT1 | 33639954 | Diagnostic | Unknown | Other | Rectal Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
ETV4 | 33639954 | Diagnostic | Unknown | Other | Rectal Cancer | Bioinformatic analysis reveals an exosomal miRNA-mRNA network in colorectal |
HOXC8 | 32176636 | Diagnostic | Unknown | Tissue | Stomach Cancer | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
HOXC8 | 32176636 | Diagnostic | Unknown | Tissue | Gastric Cancer | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
HOXC8 | 32176636 | Diagnostic | Unknown | Tissue | Cancer Related Stomach | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
FAP | 38537207 | Diagnostic | Unknown | Other | Stomach Cancer | Unusual Metastasis of Signet-Ring Cell Gastric Cancer That Could Not Be Detected |
FAP | 38286305 | Diagnostic | Unknown | Tissue | Stomach Cancer | Pachydysostosis of the fibula in a case of familial adenomatous polyposis. |
FAP | 38263336 | Diagnostic | Unknown | Other | Stomach Cancer | Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous |
FAP | 37798255 | Diagnostic | Unknown | Other | Stomach Cancer | Genotype-phenotype correlation for extracolonic aggressive phenotypes in patients |
FAP | 38537207 | Diagnostic | Unknown | Other | Gastric Cancer | Unusual Metastasis of Signet-Ring Cell Gastric Cancer That Could Not Be Detected |
FAP | 38326656 | Diagnostic | Unknown | Tissue | Gastric Cancer | Preclinical study and first-in-human imaging of [(18)F]FAP-2286, and comparison |
FAP | 38263336 | Diagnostic | Unknown | Other | Gastric Cancer | Risk of gastric adenoma and adenocarcinoma in patients with familial adenomatous |
FAP | 38286305 | Diagnostic | Unknown | Tissue | Cancer Related Stomach | Pachydysostosis of the fibula in a case of familial adenomatous polyposis. |
FAP | 37798255 | Diagnostic | Unknown | Other | Cancer Related Stomach | Genotype-phenotype correlation for extracolonic aggressive phenotypes in patients |
FAP | 35776566 | Diagnostic | Unknown | Saliva | Cancer Related Stomach | Non-oncologic incidental uptake on FAPI PET/CT imaging. |
MMP11 | 29435418 | Diagnostic | Unknown | Other | Stomach Cancer | Identification of key miRNAs and genes associated with stomach adenocarcinoma |
CST4 | 29636621 | Diagnostic | Upregulated | Tissue | Gastric Cancer | Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in |
RIPK2 | 33633788 | Diagnostic | Upregulated | Tissue | Gastric Cancer | Knockdown of RIPK2 Inhibits Proliferation and Migration, and Induces Apoptosis |
E2F3 | 31888440 | Diagnostic | Unknown | Other | Stomach Cancer | The exploration of disease-specific gene regulatory networks in esophageal |
E2F3 | 31888440 | Diagnostic | Unknown | Other | Cancer Related Stomach | The exploration of disease-specific gene regulatory networks in esophageal |
INHBA | 37304872 | Diagnostic | Upregulated | Cell lines | Stomach Cancer | MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating |
INHBA | 37304872 | Diagnostic | Upregulated | Cell lines | Gastric Cancer | MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating |
INHBA | 33828156 | Diagnostic | Downregulated | Blood | Cancer Related Stomach | Mining the plasma-proteome associated genes in patients with gastro-esophageal |
HOXC11 | 32176636 | Diagnostic | Unknown | Tissue | Stomach Cancer | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
HOXC11 | 29435418 | Diagnostic | Unknown | Other | Stomach Cancer | Identification of key miRNAs and genes associated with stomach adenocarcinoma |
HOXC11 | 32176636 | Diagnostic | Unknown | Tissue | Gastric Cancer | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
HOXC11 | 32176636 | Diagnostic | Unknown | Tissue | Cancer Related Stomach | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
COL10A1 | 32587446 | Diagnostic | Unknown | Tissue | Cancer Related Stomach | High plasma levels of COL10A1 are associated with advanced tumor stage in gastric |
SERPINH1 | 36104825 | Diagnostic | Unknown | Other | Stomach Cancer | H19 may regulate the immune cell infiltration in carcinogenesis of gastric cancer |
SERPINH1 | 32293980 | Diagnostic | Unknown | Other | Stomach Cancer | Identifying the hub gene in gastric cancer by bioinformatics analysis and in |
SERPINH1 | 36104825 | Diagnostic | Unknown | Other | Gastric Cancer | H19 may regulate the immune cell infiltration in carcinogenesis of gastric cancer |
SERPINH1 | 32293980 | Diagnostic | Unknown | Other | Gastric Cancer | Identifying the hub gene in gastric cancer by bioinformatics analysis and in |
SERPINH1 | 31249732 | Diagnostic | Upregulated | Plasma | Gastric Cancer | Discovery of plasma messenger RNA as novel biomarker for gastric cancer |
ZNF281 | 36685971 | Diagnostic | Upregulated | Tissue | Stomach Cancer | Multi-functional gene ZNF281 identified as a molecular biomarker in soft tissue |
ZNF281 | 36685971 | Diagnostic | Upregulated | Tissue | Cancer Related Stomach | Multi-functional gene ZNF281 identified as a molecular biomarker in soft tissue |
PGM2L1 | 38622522 | Diagnostic | Unknown | Tissue | Stomach Cancer | Integrating trans-omics, cellular experiments and clinical validation to identify |
PGM2L1 | 38622522 | Diagnostic | Unknown | Tissue | Gastric Cancer | Integrating trans-omics, cellular experiments and clinical validation to identify |
CST1 | 38814219 | Diagnostic | Unknown | Other | Stomach Cancer | Clinical implications and mechanism of CST1 in gastric carcinoma based on |
CST1 | 33828156 | Diagnostic | Downregulated | Blood | Stomach Cancer | Mining the plasma-proteome associated genes in patients with gastro-esophageal |
CST1 | 38814219 | Diagnostic | Unknown | Other | Gastric Cancer | Clinical implications and mechanism of CST1 in gastric carcinoma based on |
CST1 | 33828156 | Diagnostic | Downregulated | Blood | Gastric Cancer | Mining the plasma-proteome associated genes in patients with gastro-esophageal |
CST1 | 32190306 | Diagnostic | Upregulated | Other | Gastric Cancer | Identification of potential key genes in gastric cancer using bioinformatics |
CST1 | 38814219 | Diagnostic | Unknown | Other | Cancer Related Stomach | Clinical implications and mechanism of CST1 in gastric carcinoma based on |
CST1 | 33828156 | Diagnostic | Downregulated | Blood | Cancer Related Stomach | Mining the plasma-proteome associated genes in patients with gastro-esophageal |
HOXC9 | 32176636 | Diagnostic | Unknown | Tissue | Stomach Cancer | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
HOXC9 | 32176636 | Diagnostic | Unknown | Tissue | Gastric Cancer | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
HOXC9 | 32176636 | Diagnostic | Unknown | Tissue | Cancer Related Stomach | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
HOXC10 | 32176636 | Diagnostic | Unknown | Tissue | Stomach Cancer | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
HOXC10 | 32176636 | Diagnostic | Unknown | Tissue | Gastric Cancer | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
HOXC10 | 32176636 | Diagnostic | Unknown | Tissue | Cancer Related Stomach | Identification of key long non-coding RNAs in gastric adenocarcinoma. |
BGN | 35756405 | Diagnostic | Upregulated | Other | Stomach Cancer | The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence |
BGN | 35756405 | Diagnostic | Upregulated | Other | Cancer Related Stomach | The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence |
RAD51D | 25418835 | Diagnostic | Upregulated | Other | Stomach Cancer | Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage |
RAD51D | 37509701 | Diagnostic | Unknown | Other | Gastric Cancer | Heterozygous Pathogenic Nonsense Variant in the ATM Gene in a Family with |
RAD51D | 36468211 | Diagnostic | Unknown | Other | Gastric Cancer | Hereditary breast cancer: syndromes, tumour pathology and molecular testing. |
RAD51D | 25418835 | Diagnostic | Upregulated | Other | Gastric Cancer | Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage |
TUBB3 | 26396673 | Diagnostic | Unknown | Other | Gastric Cancer | Delineation of gastric cancer subtypes by co-regulated expression of receptor |